0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 21-40 of 898 Articles
JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ahmad Awada, MD, PhD; Ramon Colomer, MD, PhD; Kenichi Inoue, MD; et al.
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0237
Includes: Supplemental Content

JAMA Pediatrics | 
Editorial |  ONLINE FIRST
John M. Kelso, MD
JAMA Pediatr. Published online April 04, 2016. doi:10.1001/jamapediatrics.2016.0282

JAMA Pediatrics | 
Original Investigation |  ONLINE FIRST
Christopher Mill, MPH; Marie-Noël Primeau, MD; Elaine Medoff, MD; et al.
JAMA Pediatr. Published online April 04, 2016. doi:10.1001/jamapediatrics.2016.0033

JAMA Neurology | 
Editorial |  ONLINE FIRST
Reinhard Hohlfeld, MD; Tania Kümpfel, MD
JAMA Neurol. Published online April 04, 2016. doi:10.1001/jamaneurol.2016.0259

JAMA Neurology | 
Observation |  ONLINE FIRST
Horst Penkert, MD; Claire Delbridge, MD; Nina Wantia, MD; et al.
JAMA Neurol. Published online April 04, 2016. doi:10.1001/jamaneurol.2016.0146

JAMA Internal Medicine | 
Original Investigation | 
Loes Jaspers, MD; Frederik Feys, MSc, PhD; Wichor M. Bramer, BSc; et al.
JAMA Intern Med. 2016;176(4):453-462. doi:10.1001/jamainternmed.2015.8565.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2016;176(4):482-483. doi:10.1001/jamainternmed.2015.8597.

JAMA Internal Medicine | 
Original Investigation | 
Dima M. Qato, PharmD, MPH, PhD; Jocelyn Wilder, MPH; L. Philip Schumm, MA; et al.
JAMA Intern Med. 2016;176(4):473-482. doi:10.1001/jamainternmed.2015.8581.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Olivia Leigh Quach, MD; Sylvia Hsu, MD
JAMA Dermatol. 2016;152(4):486-487. doi:10.1001/jamadermatol.2015.4992.

JAMA Oncology | 
Editorial | 
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. 2016;2(4):437-438. doi:10.1001/jamaoncol.2015.4918.

JAMA Oncology | 
Invited Commentary | 
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. 2016;2(4):461-462. doi:10.1001/jamaoncol.2015.4682.

JAMA Oncology | 
Original Investigation | 
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. 2016;2(4):453-461. doi:10.1001/jamaoncol.2015.4655.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Filippo Montemurro, MD; Gloria Mittica, MD; Celeste Cagnazzo, PhD; et al.
JAMA Oncol. 2016;2(4):445-452. doi:10.1001/jamaoncol.2015.4720.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Maxine Sun, MPH; Toni K. Choueiri, MD; Ole-Petter R. Hamnvik, MD; et al.
JAMA Oncol. 2016;2(4):500-507. doi:10.1001/jamaoncol.2015.4917.

JAMA Oncology | 
Original Investigation | 
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. 2016;2(4):493-499. doi:10.1001/jamaoncol.2015.5570.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. 2016;2(4):529-534. doi:10.1001/jamaoncol.2015.5927.
Includes: CME

JAMA Ophthalmology | 
Observation | 
Ah Ran Cho, MD; Young Hee Yoon, MD
JAMA Ophthalmol. 2016;134(4):463-464. doi:10.1001/jamaophthalmol.2015.5966.

JAMA Neurology | 
Editorial | 
Lewis H. Kuller, MD, DrPH
JAMA Neurol. 2016;73(4):379-381. doi:10.1001/jamaneurol.2015.4931.

JAMA Neurology | 
Original Investigation | 
Willy Gomm, PhD; Klaus von Holt, MD, PhD; Friederike Thomé, MSc; et al.
JAMA Neurol. 2016;73(4):410-416. doi:10.1001/jamaneurol.2015.4791.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Rodrigue S. Allodji, PhD; Ibrahima Diallo, PhD; Chiraz El-Fayech, MD; et al.
JAMA Ophthalmol. 2016;134(4):390-397. doi:10.1001/jamaophthalmol.2015.6088.
Includes: CME, Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin
Angel Y. S. Wong, BSc; Ian C. K. Wong, PhD; Celine S. L. Chui, MSc; et al.
JAMA Neurology
Editorial  | 
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis Are There Lessons to Be Learned?
Rhonda Voskuhl, MD
JAMA Neurology
Original Investigation  | 
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
Stacy Ellen Hatcher, BS; Emmanuelle Waubant, MD, PhD; Bardia Nourbakhsh, MD; et al.
JAMA Psychiatry
Original Investigation  | 
Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence A Randomized Clinical Trial
Eugenia Oviedo-Joekes, PhD; Daphne Guh, MSc; Suzanne Brissette, MD; et al.